Cutting Edge: Programmed Death-1/Programmed Death Ligand 1 Interaction Regulates the Induction and Maintenance of Invariant NKT Cell Anergy

被引:120
|
作者
Chang, Woo-Sung [1 ,2 ]
Kim, Ji-Yeon [1 ,2 ]
Kim, Yeon-Jeong [1 ,2 ]
Kim, Yun-Sun [1 ,2 ]
Lee, Jung-Mi [1 ,2 ]
Azuma, Miyuki [3 ]
Yagita, Hideo [4 ]
Kang, Chang-Yuil [1 ,2 ]
机构
[1] Seoul Natl Univ, Coll Pharm, Immunol Lab, Seoul 151742, South Korea
[2] Seoul Natl Univ, Coll Pharm, Pharmaceut Sci Res Inst, Seoul 151742, South Korea
[3] Tokyo Med & Dent Univ, Dept Mol Immunol, Tokyo, Japan
[4] Juntendo Univ, Sch Med, Dept Immunol, Tokyo 113, Japan
来源
JOURNAL OF IMMUNOLOGY | 2008年 / 181卷 / 10期
关键词
D O I
10.4049/jimmunol.181.10.6707
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Invariant NKT (iNKT) cells are a distinct subset of T lymphocytes that recognize glycolipid Ags. Upon TCR stimulation, iNKT cells promptly secrete a wide range of cytokines and therefore have been investigated as a target for immunotherapy. However, after primary activation, iNKT cells become hyporesponsive toward their ligand (anergy). The further mechanism behind iNKT cell anergy is poorly understood. We found that a low level of programmed death-1 (PD-1) was constitutively expressed on iNKT cells and that PD-1 expression was increased after stimulation and lasted at least 2 mo. Moreover, not only did blocking of the PD-1/PD ligand 1 (PD-L1) pathway prevent the induction of anergy in iNKT cells, but anergic NKT cells also recovered responsiveness and these "rescued" cells efficiently mediated antitumor immunity. Our findings suggest that the PD-1/PD-L1 interaction is essential for the induction and maintenance of iNKT cell anergy. The Journal of Immunology, 2008,181: 6707-6710.
引用
收藏
页码:6707 / 6710
页数:4
相关论文
共 50 条
  • [1] PROGRAMMED CELL DEATH-1 INTERACTION WITH PROGRAMMED CELL DEATH LIGAND REGULATES NEURONAL CELL DEATH IN THE MOUSE RETINA
    Gandhi, N. M.
    Sham, C.
    Chen, L.
    Yang, X.
    Sharpe, A. H.
    Freeman, G.
    Braun, J.
    Gordon, L.
    JOURNAL OF INVESTIGATIVE MEDICINE, 2009, 57 (01) : 237 - 237
  • [2] Tumor Progression by Immune Evasion in Melanoma Role of the Programmed Cell Death-1/Programmed Cell Death-1 Ligand 1 Interaction
    Kashani-Sabet, Mohammed
    CANCER, 2010, 116 (07) : 1623 - 1625
  • [3] Interaction of Programmed Death-1 and Programmed Death-1 Ligand-1 Contributes to Testicular Immune Privilege
    Cheng, Xuyang
    Dai, Hehua
    Wan, Ni
    Moore, Yolonda
    Vankayalapati, Ramakrishna
    Dai, Zhenhua
    TRANSPLANTATION, 2009, 87 (12) : 1778 - 1786
  • [4] B7-H1 (programmed death-1 ligand) on dendritic cells is involved in the induction and maintenance of T cell anergy
    Selenko-Gebauer, N
    Majdic, O
    Szekeres, A
    Höfler, G
    Guthann, E
    Korthäuer, U
    Zlabinger, G
    Steinberger, P
    Pickl, WF
    Stockinger, H
    Knapp, W
    Stöckl, J
    JOURNAL OF IMMUNOLOGY, 2003, 170 (07): : 3637 - 3644
  • [5] Discovery of the programmed cell death-1/programmed cell death-ligand 1 interaction inhibitors bearing an indoline scaffold
    Qin, Mingze
    Cao, Qi
    Wu, Xia
    Liu, Chunyang
    Zheng, Shuaishuai
    Xie, Hongbo
    Tian, Ye
    Xie, Jun
    Zhao, Yanfang
    Hou, Yunlei
    Zhang, Xian
    Xu, Boxuan
    Zhang, Haotian
    Wang, Xiaobo
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2020, 186
  • [6] SAR study of small molecule inhibitors of the programmed cell death-1/programmed cell death-ligand 1 interaction
    Kawashita, Seiji
    Aoyagi, Koichi
    Fukushima, Kyoko
    Hantani, Rie
    Naruoka, Shiori
    Tanimoto, Atsuo
    Hori, Yuji
    Toyonaga, Yukiyo
    Yamanaka, Hiroshi
    Miyazaki, Susumu
    Hantani, Yoshiji
    CHEMICAL BIOLOGY & DRUG DESIGN, 2021, 98 (05) : 914 - 929
  • [7] Programmed Cell Death-1/Programmed Cell Death-1 Ligand as Prognostic Markers of Coronavirus Disease 2019 Severity
    Niedzwiedzka-Rystwej, Paulina
    Majchrzak, Adam
    Aksak-Was, Bogusz
    Serwin, Karol
    Czajkowski, Zenon
    Grywalska, Ewelina
    Korona-Glowniak, Izabela
    Rolinski, Jacek
    Parczewski, Milosz
    CELLS, 2022, 11 (12)
  • [8] Programmed Cell Death-1/Programmed Death-ligand 1 Pathway: A New Target for Sepsis
    Liu Qiang
    Li Chun-Sheng
    中华医学杂志英文版, 2017, 130 (08) : 986 - 992
  • [9] Programmed Cell Death-1/Programmed Death-ligand 1 Pathway: A New Target for Sepsis
    Liu, Qiang
    Li, Chun-Sheng
    CHINESE MEDICAL JOURNAL, 2017, 130 (08) : 986 - 992
  • [10] Programmed cell death-1 and programmed cell death ligand-1 antibodies-induced dysthyroidism
    Jaafar, Jaafar
    Fernandez, Eugenio
    Alwan, Heba
    Philippe, Jacques
    ENDOCRINE CONNECTIONS, 2018, 7 (05): : R196 - R211